https://www.agencyiq.com/ 2026-10-12T04:47:47+00:00 https://www.agencyiq.com/life-sciences-analysis-what-we-expect-the-fda-to-do-in-may-and-june-2024/ 2024-05-03T15:52:04+00:00 https://www.agencyiq.com/analysis-chemical-what-we-expect-the-epa-to-do-in-may-2024/ 2024-05-03T16:02:10+00:00 https://www.agencyiq.com/article-fda-with-the-new-ldt-final-rule-fda-works-to-clarify-what-emergency-response-will-look-like-going-forward/ 2024-05-03T16:07:47+00:00 https://www.agencyiq.com/article-ema-what-we-expect-european-regulators-to-do-in-may-2024/ 2024-05-03T16:18:36+00:00 https://www.agencyiq.com/analysis-life-sciences-what-life-sciences-companies-need-to-know-about-nists-new-ai-guidance/ 2024-05-10T16:16:41+00:00 https://www.agencyiq.com/analysis-chemical-how-states-are-looking-to-control-pfas-through-different-legislative-models/ 2024-05-10T16:24:45+00:00 https://www.agencyiq.com/article-fda-fda-holds-the-line-on-remanufacturing-definitions-in-newly-finalized-guidance/ 2024-05-10T16:30:46+00:00 https://www.agencyiq.com/article-ema-european-ombudsman-suggests-commission-needs-more-robust-evidence-when-reclassifying-medical-devices/ 2024-05-10T16:38:54+00:00 https://www.agencyiq.com/article-periodic-what-we-expect-eu-chemical-regulators-to-do-in-may-2024/ 2024-05-10T16:56:47+00:00 https://www.agencyiq.com/article-periodic-france-reintroduces-pesticide-plan-this-time-with-eu-indicator/ 2024-05-10T16:57:46+00:00 https://www.agencyiq.com/analysis-life-sciences-how-have-pre-submission-meetings-for-generic-drug-applicants-changed-under-gdufa-iii/ 2024-05-17T19:34:39+00:00 https://www.agencyiq.com/analysis-chemical-maryland-governor-signs-bill-focused-on-pfas-discharges-in-wastewater/ 2024-05-17T19:41:07+00:00 https://www.agencyiq.com/article-fda-house-legislators-set-to-markup-legislation-related-to-rare-diseases-pediatric-oncology-and-hct-ps/ 2024-05-17T19:57:08+00:00 https://www.agencyiq.com/article-ema-real-world-data-in-non-interventional-studies-addressed-in-new-ema-reflection-paper/ 2024-05-17T20:22:45+00:00 https://www.agencyiq.com/article-periodic-epas-toxicological-review-of-pfna-gets-mixed-reviews-from-government-industry/ 2024-05-17T20:35:20+00:00 https://www.agencyiq.com/analysis-life-sciences-eampc-lawmakers-grill-directors-of-fda-medical-product-centers/ 2024-05-28T15:53:01+00:00 https://www.agencyiq.com/analysis-chemical-updates-to-tsca-new-chemicals-regulations-hit-oira-for-review/ 2024-05-28T15:57:06+00:00 https://www.agencyiq.com/article-fda-new-fda-guidance-on-addressing-misinformation-under-white-house-review/ 2024-05-28T16:04:52+00:00 https://www.agencyiq.com/article-ema-u-k-regulator-lays-out-proposal-for-international-device-and-diagnostics-recognition/ 2024-05-28T16:10:45+00:00 https://www.agencyiq.com/article-periodic-commission-issues-methodology-to-measure-microplastics-in-drinking-water/ 2024-05-28T16:17:18+00:00 https://www.agencyiq.com/analysis-life-sciences-unpacking-fdas-long-awaited-platform-technology-designation-program-and-guidance/ 2024-05-31T17:01:23+00:00 https://www.agencyiq.com/analysis-chemical-what-we-expect-the-epa-to-do-in-june-2024/ 2024-05-31T17:07:55+00:00 https://www.agencyiq.com/article-fda-adcomm-votes-in-favor-of-new-colorectal-cancer-screening-test-but-questions-about-serial-testing-and-labeling-remain/ 2024-05-31T18:18:50+00:00 https://www.agencyiq.com/article-ema-what-we-expect-european-regulators-to-do-in-june-2024/ 2024-05-31T18:27:36+00:00 https://www.agencyiq.com/article-periodic-what-we-expect-eu-chemical-regulators-to-do-in-june-2024/ 2024-05-31T18:33:13+00:00 https://www.agencyiq.com/analysis-life-sciences-the-fda-tried-to-call-the-dietary-supplement-industrys-bluff-it-appears-to-have-blinked/ 2024-06-07T16:02:53+00:00 https://www.agencyiq.com/analysis-chemical-epa-proposes-risk-management-actions-for-nmp/ 2024-06-07T16:08:36+00:00 https://www.agencyiq.com/article-fda-fdas-new-guidance-explains-what-to-do-during-a-bimo-inspection/ 2024-06-07T16:17:34+00:00 https://www.agencyiq.com/article-ema-the-devil-is-in-the-details-a-deep-dive-into-the-state-of-notified-body-designations/ 2024-06-07T16:24:05+00:00 https://www.agencyiq.com/article-periodic-european-commission-issues-eu-wide-rules-on-pesticide-ingredients/ 2024-06-07T16:42:43+00:00 https://www.agencyiq.com/analysis-life-sciences-another-monoclonal-antibody-for-early-alzheimers-sees-strong-advisory-committee-support/ 2024-06-17T16:53:22+00:00 https://www.agencyiq.com/analysis-chemical-a-year-into-the-epas-pfas-framework-for-new-chemicals-what-is-the-agency-approving/ 2024-06-17T17:05:21+00:00 https://www.agencyiq.com/article-fda-in-unanimous-decision-supreme-court-solves-fdas-standing-issue/ 2024-06-17T17:19:47+00:00 https://www.agencyiq.com/article-ema-new-mdr-ivdr-standardization-request-adds-standards-moves-deadlines/ 2024-06-17T17:28:20+00:00 https://www.agencyiq.com/article-periodic-swiss-regulators-align-with-eu-on-chemicals-biocides/ 2024-06-17T17:33:36+00:00 https://www.agencyiq.com/analysis-life-sciences-cbers-peter-marks-offers-insights-on-a-new-rare-disease-hub-upcoming-accelerated-approval-guidance/ 2024-06-21T20:25:35+00:00 https://www.agencyiq.com/analysis-chemical-proposed-limits-for-pfas-in-industrial-discharges-head-to-oira/ 2024-06-21T20:36:35+00:00 https://www.agencyiq.com/article-fda-fda-finalizes-guidance-extending-inspection-authority-to-medical-devices/ 2024-06-21T20:44:17+00:00 https://www.agencyiq.com/article-ema-commission-proposes-guidelines-to-flesh-out-the-newly-finalized-variations-regulation/ 2024-06-21T20:51:34+00:00 https://www.agencyiq.com/article-periodic-echa-committees-conclude-evaluation-of-several-pfas-uses-subject-to-proposed-restrictions/ 2024-06-21T20:55:18+00:00 https://www.agencyiq.com/analysis-life-sciences-fda-just-published-its-diversity-action-plan-guidance-heres-what-you-need-to-know/ 2024-06-28T16:13:50+00:00 https://www.agencyiq.com/analysis-chemical-what-we-expect-the-epa-to-do-in-july-2024/ 2024-06-28T16:24:11+00:00 https://www.agencyiq.com/article-fda-fda-draft-guidance-on-addressing-misinformation-clears-white-house-review/ 2024-06-28T16:33:08+00:00 https://www.agencyiq.com/article-ema-new-guidance-provides-definition-for-orphan-device-offers-alternative-trial-designs/ 2024-06-28T16:38:36+00:00 https://www.agencyiq.com/article-periodic-why-comprehensive-state-level-bans-on-pfas-in-products-are-faltering/ 2024-06-28T16:44:00+00:00 https://www.agencyiq.com/analysis-life-sciences-what-we-expect-the-fda-to-do-in-july-and-august-2024/ 2024-07-08T17:39:20+00:00 https://www.agencyiq.com/analysis-chemical-supreme-court-significantly-expands-time-to-file-lawsuits-over-agency-regulations/ 2024-07-08T17:51:55+00:00 https://www.agencyiq.com/article-fda-in-a-new-final-rule-fda-carves-out-a-regulatory-niche-for-medical-gases/ 2024-07-08T18:01:29+00:00 https://www.agencyiq.com/article-ema-what-we-expect-european-regulators-to-do-in-july-2024/ 2024-07-08T18:09:57+00:00 https://www.agencyiq.com/article-periodic-epa-publishes-interagency-framework-on-antifungal-and-antibiotic-resistance-from-pesticides/ 2024-07-08T18:14:41+00:00 https://www.agencyiq.com/analysis-life-sciences-the-53-regulations-that-fda-is-currently-working-on/ 2024-07-12T15:39:39+00:00 https://www.agencyiq.com/analysis-chemical-litigants-pile-into-ethylene-oxide-rule-review-at-d-c-circuit/ 2024-07-12T15:44:42+00:00 https://www.agencyiq.com/article-fda-fda-gives-companies-leeway-to-go-after-misinformation-but-not-free-reign/ 2024-07-12T15:49:38+00:00 https://www.agencyiq.com/article-ema-new-ec-report-dives-deep-to-better-understand-shortages-of-critical-medicines/ 2024-07-12T15:55:26+00:00 https://www.agencyiq.com/article-periodic-epa-grants-petition-on-pfas-in-fluorinated-containers/ 2024-07-12T16:03:27+00:00 https://www.agencyiq.com/analysis-life-sciences-halfway-there-novel-drug-approvals-and-their-supportive-clinical-trials-so-far-in-2024/ 2024-07-22T21:24:27+00:00 https://www.agencyiq.com/analysis-chemical-the-103-regulations-the-epa-is-currently-working-on/ 2024-07-22T21:29:37+00:00 https://www.agencyiq.com/article-fda-facing-headwinds-fda-moves-ahead-on-diagnostics-policy-implementation-but-faces-congressional-legal-and-judicial-questions/ 2024-07-22T21:36:05+00:00 https://www.agencyiq.com/article-ema-updated-eudamed-roadmap-projects-mandatory-use-of-some-processes-as-early-as-december-2025/ 2024-07-22T21:41:26+00:00 https://www.agencyiq.com/commission-unveils-details-on-plan-for-phasing-out-animal-testing-for-chemicals-safety/ 2024-07-22T21:45:51+00:00 https://www.agencyiq.com/analysis-life-sciences-fdas-new-guidance-on-postapproval-manufacturing-changes-for-biosimilars-focuses-on-current-practice-new-dosage-forms/ 2024-07-26T16:14:48+00:00 https://www.agencyiq.com/article-fda-fda-finalizes-guidance-on-electronic-submissions-for-otc-products/ 2024-07-26T16:24:18+00:00 https://www.agencyiq.com/article-ema-top-ivdr-notified-body-concern-lack-of-e-u-reference-laboratories-for-high-risk-diagnostics/ 2024-07-26T16:30:06+00:00 https://www.agencyiq.com/article-periodic-eu-executive-consults-on-proposed-update-to-pic-chemical-lists/ 2024-07-26T16:34:47+00:00 https://www.agencyiq.com/analysis-life-sciences-what-we-expect-the-fda-to-do-in-august-and-september-2024/ 2024-08-02T15:45:24+00:00 https://www.agencyiq.com/analysis-chemical-what-we-expect-eu-chemical-regulators-to-do-in-august-2024/ 2024-08-02T15:51:07+00:00 https://www.agencyiq.com/article-fda-digital-health-update-hhs-new-ai-office-fdas-report-on-ai-in-surveillance-and-coming-policy/ 2024-08-02T15:57:38+00:00 https://www.agencyiq.com/article-ema-what-we-expect-european-regulators-to-do-in-august-and-september-2024/ 2024-08-02T16:45:19+00:00 https://www.agencyiq.com/analysis-life-sciences-fdas-diversity-action-plan-questions-answers-and-what-we-dont-know-so-far/ 2024-08-09T16:16:02+00:00 https://www.agencyiq.com/article-fda-fdas-new-metabolic-diseases-committee-gives-hesitant-nod-to-ultra-rare-disease-drug/ 2024-08-09T16:20:31+00:00 https://www.agencyiq.com/article-ema-emas-psychedelic-workshop-leaves-stakeholders-with-as-many-questions-as-answers/ 2024-08-09T16:32:18+00:00 https://www.agencyiq.com/article-periodic-commission-proposes-exemptions-to-uv-328-ban-under-pops-regulation/ 2024-08-09T16:38:18+00:00 https://www.agencyiq.com/analysis-life-sciences-fda-solidifies-its-advice-on-dose-optimization-for-oncology-products/ 2024-08-16T16:52:19+00:00 https://www.agencyiq.com/article-fda-the-fda-rejected-a-psychedelic-sponsors-bid-for-approval-here-are-six-industry-takeaways/ 2024-08-16T16:58:13+00:00 https://www.agencyiq.com/article-periodic-are-eu-substitution-centers-in-the-cards-for-quicker-substitution-of-toxic-chemicals/ 2024-08-16T17:34:23+00:00 https://www.agencyiq.com/analysis-life-sciences-cdrh-unveils-new-guidance-on-pre-determined-change-control-plans-for-medical-devices/ 2024-08-23T15:59:27+00:00 https://www.agencyiq.com/article-fda-whats-on-fdas-new-diagnostics-chiefs-mind-transitions-the-ldt-rule-and-cybersecurity/ 2024-08-23T16:04:40+00:00 https://www.agencyiq.com/article-ema-ema-issues-more-updates-to-prepare-for-clinical-trials-transition/ 2024-08-23T16:10:09+00:00 https://www.agencyiq.com/article-periodic-echa-issues-guidelines-for-enforcing-mixture-classification-based-on-bridging-principles/ 2024-08-23T16:14:52+00:00 https://www.agencyiq.com/analysis-life-sciences-fda-finalizes-inaugural-guidance-allowing-certain-device-makers-to-submit-quarterly-malfunction-reports/ 2024-08-30T19:05:28+00:00 https://www.agencyiq.com/analysis-chemical-what-we-expect-eu-chemical-regulators-to-do-in-september-2024/ 2024-08-30T19:12:40+00:00 https://www.agencyiq.com/article-fda-fda-adcomm-to-discuss-patient-centric-informed-consent/ 2024-08-30T19:16:27+00:00 https://www.agencyiq.com/article-ema-what-we-expect-european-regulators-to-do-in-september-2024/ 2024-08-30T19:29:37+00:00 https://www.agencyiq.com/article-periodic-an-introduction-to-eu-chemicals-guidance/ 2024-08-30T19:35:14+00:00 https://www.agencyiq.com/analysis-chemical-what-does-trumps-order-on-deregulation-mean-for-the-chemicals-industry/ 2025-02-14T15:05:06+00:00 https://www.agencyiq.com/analysis-life-sciences-five-critical-challenges-awaiting-marty-makary/ 2025-04-18T19:56:59+00:00 https://www.agencyiq.com/analysis-chemical-trumps-make-america-healthy-again-commission-could-lead-to-action-on-chemicals/ 2025-04-22T17:44:49+00:00 https://www.agencyiq.com/analysis-life-sciences-a-new-executive-order-calls-for-fda-to-promote-domestic-manufacturing-but-with-plenty-of-practical-concerns/ 2025-05-22T16:29:47+00:00 https://www.agencyiq.com/analysis-food-fda-usda-take-first-steps-to-define-ultra-processed-foods/ 2025-08-04T20:02:13+00:00 https://www.agencyiq.com/analysis-what-we-expect-the-fda-to-do-in-october-and-november-2025/ 2025-10-14T19:58:35+00:00 https://www.agencyiq.com/analysis-life-sciences-makarys-push-to-approve-more-otc-drugs-could-test-fdas-new-regulatory-tools/ 2026-02-11T21:35:40+00:00 https://www.agencyiq.com/analysis-food-fda-plans-to-target-added-sugar-with-industry-focused-reduction-strategy/ 2026-02-11T21:39:38+00:00 https://www.agencyiq.com/analysis-chemical-fda-publishes-draft-guidance-detailing-agency-authority-over-cosmetic-records/ 2026-02-11T21:40:06+00:00 https://www.agencyiq.com/analysis-food-prevention-and-treatment-a-major-focus-of-fdas-food-allergy-regulatory-push/ 2026-03-10T21:03:34+00:00 https://www.agencyiq.com/analysis-chemical-senate-tsca-draft-redefines-conditions-of-use-adds-tiered-review-system/ 2026-03-10T21:04:52+00:00 https://www.agencyiq.com/analysis-life-sciences-white-house-reviewing-fda-proposed-rule-on-distributed-manufacturing-foreign-facility-registration/ 2026-03-10T21:07:05+00:00 https://www.agencyiq.com/analysis-chemical-fda-revokes-aoac-methods-of-analysis-policy-affecting-food-and-cosmetic-testing/ 2026-03-10T21:08:30+00:00 https://www.agencyiq.com/analysis-food-fda-clarifies-applicability-of-food-traceability-rule-with-new-draft-qa-guidance/ 2026-03-10T21:09:47+00:00 https://www.agencyiq.com/analysis-life-sciences-fda-emphasizes-study-quality-in-shift-to-one-trial-default-for-drug-approval/ 2026-03-10T21:11:18+00:00 https://www.agencyiq.com/analysis-life-sciences-new-fda-guidance-encourages-nams-adoption-but-keeps-advice-broad/ 2026-03-25T15:13:31+00:00 https://www.agencyiq.com/analysis-food-how-stakeholder-feedback-might-shape-a-federal-definition-of-ultra-processed-foods/ 2026-03-25T15:14:32+00:00 https://www.agencyiq.com/analysis-chemical-nitrous-oxide-face-eu-consumer-ban-under-reach-proposal/ 2026-03-25T15:26:57+00:00 https://www.agencyiq.com/analysis-life-sciences-fdas-fy-2027-budget-request-previews-agency-priorities-reduced-appropriated-funding/ 2026-04-08T15:15:51+00:00 https://www.agencyiq.com/analysis-food-fda-maps-out-scientific-agenda-for-human-foods-program/ 2026-04-08T15:21:19+00:00 https://www.agencyiq.com/analysis-food-stakeholders-split-in-feedback-to-fda-on-bhas-safety-and-use-in-foods/ 2026-04-23T00:53:56+00:00 https://www.agencyiq.com/analysis-life-sciences-fda-fills-out-genome-editing-product-guidance-with-new-safety-recommendations/ 2026-04-23T01:03:45+00:00 https://www.agencyiq.com/analysis-life-sciences-odac-meeting-part-1-fdas-advisors-unconvinced-of-ctdna-strategy-for-metastatic-breast-cancer/ 2026-05-06T18:15:54+00:00 https://www.agencyiq.com/analysis-food-house-hearing-on-fda-food-regulation-spotlights-coming-debate-over-scope-and-scale-of-reforms/ 2026-05-06T19:01:42+00:00 https://www.agencyiq.com/analysis-food-fda-finalizes-postmarket-food-chemical-assessment-framework/ 2026-05-20T20:04:43+00:00 https://www.agencyiq.com/analysis-life-sciences-more-fda-leaders-are-departing-heres-what-the-turmoil-may-mean-for-agency-policies-and-priorities/ 2026-05-20T20:10:00+00:00 https://www.agencyiq.com/analysis-life-sciences-final-human-factors-submissions-guidance-offers-revamped-documentation-system/ 2026-06-04T15:35:41+00:00 https://www.agencyiq.com/analysis-food-fda-nears-next-closer-to-zero-milestone-with-forthcoming-cadmium-guidance/ 2026-06-04T15:43:43+00:00 https://www.agencyiq.com/analysis-food-house-advances-ag-fda-funding-bill-with-new-food-regulatory-directives/ 2026-06-15T19:36:40+00:00 https://www.agencyiq.com/analysis-life-sciences-new-house-bill-seeks-overhaul-of-laboratory-developed-test-regulation/ 2026-06-16T17:58:53+00:00 https://www.agencyiq.com/analysis-food-californias-food-allergen-labeling-law-to-hit-menus-july-1/ 2026-07-01T17:04:44+00:00 https://www.agencyiq.com/analysis-life-sciences-making-sense-of-operation-trialblazer-whats-in-hhss-research-reform-plan/ 2026-07-01T17:20:02+00:00 https://www.agencyiq.com/analysis-food-the-2026-unified-agenda-is-out-heres-what-it-covers-in-food-and-chemicals-regulation/ 2026-07-15T16:21:40+00:00 https://www.agencyiq.com/analysis-life-sciences-what-to-make-of-the-fdas-latest-crl-drop/ 2026-07-15T16:30:01+00:00 https://www.agencyiq.com/analysis-life-sciences-advisory-panel-votes-pressure-fda-to-allow-access-to-compounded-peptides/ 2026-07-29T18:22:19+00:00 https://www.agencyiq.com/analysis-food-companies-look-to-federal-preemption-to-fend-off-california-upf-lawsuit-invoking-supreme-court-pesticide-case/ 2026-07-29T18:31:11+00:00 https://www.agencyiq.com/analysis-food-fdas-gras-rule-is-here-with-mandatory-notification-streamlined-reporting-and-some-exemptions/ 2026-08-11T15:03:11+00:00 https://www.agencyiq.com/analysis-life-sciences-at-mdufa-vi-meeting-fda-revealed-fee-updates-program-changes-and-next-steps/ 2026-08-11T15:10:17+00:00 https://www.agencyiq.com/analysis-life-sciences-heidi-overton-is-trumps-pick-for-next-fda-commissioner-heres-what-to-know/ 2026-08-25T15:37:40+00:00 https://www.agencyiq.com/analysis-food-fda-finalizes-long-awaited-fresh-cut-produce-guidance-as-outbreaks-put-prevention-in-focus/ 2026-08-25T15:39:51+00:00 https://www.agencyiq.com/analysis-life-sciences-fdas-new-genai-draft-framework-risk-assessments-and-extended-responsibility/ 2026-08-25T15:40:21+00:00 https://www.agencyiq.com/analysis-food-the-fdas-gras-proposal-could-strain-capacity-and-create-review-bottlenecks/ 2026-09-09T18:16:55+00:00 https://www.agencyiq.com/analysis-life-sciences-a-primer-on-fdas-accessories-classification-process-and-regulatory-confusion/ 2026-09-09T18:22:28+00:00 https://www.agencyiq.com/analysis-life-sciences-fda-launches-expedited-ind-pilot-fills-in-details-on-its-design/ 2026-09-23T20:49:33+00:00 https://www.agencyiq.com/analysis-food-california-bill-would-require-restaurant-warning-labels-for-sugary-beverages/ 2026-09-23T20:55:37+00:00 https://www.agencyiq.com/analysis-life-sciences-new-fda-transparency-roadmap-foreshadows-major-changes-to-trial-data-and-more/ 2026-10-08T18:17:15+00:00 https://www.agencyiq.com/analysis-food-passage-of-food-safety-bill-in-senate-improves-chances-for-fda-reforms-this-session/ 2026-10-08T18:24:59+00:00